קריסויטה 10 מג ישראל - עברית - Ministry of Health

קריסויטה 10 מג

medison pharma ltd - burosumab - תמיסה להזרקה - burosumab 10 mg / 1 ml - burosumab

קריסויטה 20 מג ישראל - עברית - Ministry of Health

קריסויטה 20 מג

medison pharma ltd - burosumab - תמיסה להזרקה - burosumab 20 mg / 1 ml - burosumab

קריסויטה 30 מג ישראל - עברית - Ministry of Health

קריסויטה 30 מג

medison pharma ltd - burosumab - תמיסה להזרקה - burosumab 30 mg / 1 ml - burosumab

צייטוטק 200 מקג טבליות ישראל - עברית - Ministry of Health

צייטוטק 200 מקג טבליות

pfizer pfe pharmaceuticals israel ltd - misoprostol - טבליה - misoprostol 200 mcg - misoprostol - misoprostol - for the treatment of duodenal and gastric ulcer.treatment and prevention nsaid induced ulcers lesions, erosions, while nsaid therapy continues.use in conjunction with mifepristone subject to the approval of a committee for the termination of pregnancy according to the israeli penal law 1977.first-trimester pregnancy failure: use is intended for emptying the uterus in states of first trimester pregnancy failure, including: presentation of a pregnancy sac in the uterus with no fetal echo, missed abortion (until week 11+6 and a fetus 40 mm in length) or incomplete abortion. the preparation is to be used after location of the sac in the uterus has been proved and the diagnosis of pregnancy failure is certain. the preparation can be used for this purpose in an ambulatory setting. the dosage and route of administration will be similar to the use of cytotec in pregnancy termination after using mifegyne. informed consent and medical surveillance are required.softening and dilation of the cervix for performing intraut

ארטרוטק 75 ישראל - עברית - Ministry of Health

ארטרוטק 75

pfizer pharmaceuticals israel ltd - diclofenac sodium 75 mg; misoprostol 200 mcg - tablets - diclofenac - for patients requiring longterm anti-inflammatory treatment, in such circumstances where there is a high risk of developing hemorrhage or ulcer i.e. patients with a peptic ulcer or past gastric bleeding, patients with cardiovascular disease, patients over 65 and smokers.

איזופלוראן יו.אס.פי טרל ישראל - עברית - Ministry of Health

איזופלוראן יו.אס.פי טרל

pharma medis - isoflurane - נוזל לשאיפה - isoflurane 100 %v/v - isoflurane - isoflurane - general inhalation anesthetic.

סוג'ורן סבופלוראן יו אס פי ישראל - עברית - Ministry of Health

סוג'ורן סבופלוראן יו אס פי

pharma medis - sevoflurane - נוזל - sevoflurane 100 %v/v - sevoflurane - sevoflurane - general inhalation anesthetic.

גאמונקס  - סי ישראל - עברית - Ministry of Health

גאמונקס - סי

padagis israel agencies ltd, israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 0.1 g/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - gamunex is indicated as replacement therapy of primary immunodeficiency (pi) states in which severe impaiment of antibody forming capacity has been shown, such as congential agammaglobulinemia, common variable immunodeficiency, x-limked immunodeficiency with hyper igm, wiskott- aldrich syndrom, and severed combined immunodeficiencies. gamunex is also indicated in idiopathic thrombocytopenia purpura (itp) to raise platelet counts to prevent bleeding or to allow a patient with itp to undergo surgery.treatment of chronic inflammatory demyelinating polyneuropathy (cidp).

Dermal Filler Based on Hyalronic Acid ישראל - עברית - Ministry of Health

dermal filler based on hyalronic acid

סלע מדיקל בע"מ - רופא - משתל למילוי קמטים

בריגלובין פי. ישראל - עברית - Ministry of Health

בריגלובין פי.

csl behring ltd., israel - immunoglobulins, normal human - תמיסה להזרקה - immunoglobulins, normal human 160 mg/ml - immunoglobulins, normal human, for extravascular adm. - immunoglobulins, normal human, for extravascular adm. - substitution in - primary antibody deficiency syndromes resulting from defective antibody synthesis. - protracted transitory hypogammaglobulinaemia especially in premature infants .prophylaxis of hepatitis a- before exposure- within 2 weeks after exposure